SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-016377
Filing Date
2023-03-06
Accepted
2023-03-06 17:03:58
Documents
1
Period of Report
2023-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8575
  Complete submission text file 0001209191-23-016377.txt   9933
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Pierce Valerie L (Reporting) CIK: 0001397112 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38853 | Film No.: 23709769

Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations